| 摘要 |
<p>PROBLEM TO BE SOLVED: To provide a pharmaceutical formulation which can be aimed at an elimination of formulation additives or adjuvant, and is excellent in stability and sterility, while enabling shortening of a development duration of pharmaceutical formulations, and to provide a producing method thereof.SOLUTION: A pharmaceutical formulation of the invention consists of a first formulation component and a second formulation component. The first formulation component is an active substance consisting of an active ingredient and a solvent only. The active ingredient is any of a protein formulation component, a nucleic acid formulation component, or a vaccine-formulation component. If the active ingredient is the protein formulation component or the nucleic acid formulation component, the second formulation component contains at least one kind of the formulation additives, and if the active ingredient is the vaccine-formulation component, at least one kind of adjuvants and/or the formulation additives are contained. The second formulation component is used by mixing with the first formulation component just before administration.</p> |
